NasdaqCM - Nasdaq Real Time Price USD

Waldencast plc (WALD)

Compare
3.4100 +0.0300 (+0.89%)
As of 12:01 PM EDT. Market Open.
Loading Chart for WALD
DELL
  • Previous Close 3.3800
  • Open 3.4000
  • Bid 3.4000 x 100
  • Ask 3.4500 x 100
  • Day's Range 3.3853 - 3.5800
  • 52 Week Range 2.4050 - 12.0000
  • Volume 4,456
  • Avg. Volume 240,770
  • Market Cap (intraday) 444.265M
  • Beta (5Y Monthly) -0.55
  • PE Ratio (TTM) --
  • EPS (TTM) -0.7400
  • Earnings Date Nov 20, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 5.75

Waldencast plc operates in the beauty and wellness industry. It engages in developing, acquiring, accelerating, and scaling various brands. The company provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians. It also offers clean makeup products under the Milk Makeup brand. The company sells its products to dermatologists, plastic surgeons, and other physicians who focuses on aesthetic and therapeutic skincare, including physicians on site at medical spas, through its direct sales force, as well as through distribution partners. Waldencast plc was incorporated in 2020 and is headquartered in White Plains, New York.

www.waldencast.com

284

Full Time Employees

December 31

Fiscal Year Ends

Recent News: WALD

View More

Performance Overview: WALD

Trailing total returns as of 10/8/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

WALD
68.83%
S&P 500
20.32%

1-Year Return

WALD
61.90%
S&P 500
33.21%

3-Year Return

WALD
65.27%
S&P 500
30.44%

5-Year Return

WALD
65.38%
S&P 500
41.26%

Compare To: WALD

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: WALD

View More

Valuation Measures

Annual
As of 10/7/2024
  • Market Cap

    414.60M

  • Enterprise Value

    583.40M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.43

  • Price/Book (mrq)

    0.67

  • Enterprise Value/Revenue

    2.43

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -29.39%

  • Return on Assets (ttm)

    -4.42%

  • Return on Equity (ttm)

    -10.74%

  • Revenue (ttm)

    240.38M

  • Net Income Avi to Common (ttm)

    -70.64M

  • Diluted EPS (ttm)

    -0.7400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    19.69M

  • Total Debt/Equity (mrq)

    24.79%

  • Levered Free Cash Flow (ttm)

    8.76M

Research Analysis: WALD

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 65.79M
Earnings -5.04M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

4.00
5.75 Average
3.4100 Current
7.25 High
 

Company Insights: WALD

People Also Watch